In this Customer Conversation, two global leaders—EUROIMMUN, a pioneer in medical laboratory diagnostics, and Omni International, a leading manufacturer of laboratory homogenizers—come together to explore the evolving world of diagnostic and companion diagnostic (CDx) testing.
Dr. Maite Sabalza, a driving force behind EUROIMMUN’s innovative diagnostic assay development, joins Gabriella Ryan, Senior Application Scientist at Omni, for a forward-thinking discussion on the technologies, trends, and global health implications shaping modern diagnostics.
Key highlights include EUROIMMUN’s rapid response to emerging infectious diseases such as Oropouche virus, the growing importance of at-home diagnostic testing, advances in genetic and hormone assay development, and the critical role of sample prep and homogenization in ensuring diagnostic accuracy and scalability.
Whether you're in translational research, clinical diagnostics, or biotech innovation, this conversation offers timely insights into how collaboration and scientific rigor are pushing the boundaries of what's possible in human health.
Topics Covered:
• Emerging disease diagnostics
• Genetic and hormone assay development
• At-home testing trends
• Companion diagnostics (CDx)
• Role of sample prep in assay performance
• EUROIMMUN’s global impact and scientific innovation
For more information on omni sample prep products, visit omni-inc.com/
EUROIMMUN, Omni International, diagnostic testing, companion diagnostics, CDx development, clinical diagnostics, laboratory homogenizer, diagnostic assay development, Oropouche virus testing, at-home diagnostic testing, genetic assay development, hormone testing, medical diagnostics innovation, global health diagnostics, infectious disease testing, diagnostic sample preparation, translational research tools, Gabriella Ryan, Maite Sabalza, medical lab diagnostics, emerging disease diagnostics, diagnostic technology trends, sample prep for diagnostics, diagnostic testing innovations, customer conversation.
コメント